Literature DB >> 10729248

Regenerative capacities of normal and cirrhotic livers following 70% hepatectomy in rats and the effect of alpha-tocopherol on cirrhotic regeneration.

F Andiran1, A Ayhan, F C Tanyel, O Abbasoğlu, I Sayek.   

Abstract

BACKGROUND: The regeneration of normal and cirrhotic liver has been very well demonstrated after partial hepatectomy; although the tissue regenerated by cirrhotic liver is also cirrhotic. The structural differences of the regenerated tissues between normal and cirrhotic livers may also indicate different regeneration capacities. The objective of this study was to compare the regeneration capacities of normal and cirrhotic livers by bromodeoxyuridine (BrdU) incorporation and proliferating cell nuclear antigen (PCNA) labeling indices in replicating nuclei and mitotic figures in cells in partially hepatectomized normal and cirrhotic rats and to study the effect of alpha-tocopherol on cirrhotic liver regeneration.
METHODS: Five groups of adult Wistar rats comprised normal livers, cirrhotic livers, regenerated normal livers, regenerated cirrhotic livers, and alpha-tocopherol-treated regenerated cirrhotic livers. Cirrhosis was induced by intragastric administration of carbon tetrachloride and phenobarbital in the drinking water of the rats. Liver regeneration capacities in normal and cirrhotic rats and following partial hepatectomy in normal and cirrhotic rats and cirrhotic rats that were administered alpha-tocopherol were evaluated through BrdU incorporation, PCNA labeling, and mitotic indices.
RESULTS: BrdU and PCNA labeling and mitotic indices were zero for normal rats and 4.3 +/- 3.5, 6.5 +/- 5, and 2.5 +/- 1.5 for cirrhotic rats, respectively. The values after partial hepatectomy in normal and cirrhotic rats were 46.2 +/- 8.7 and 27.8 +/- 7.5 for BrdU labeling, 83.7 +/- 6.5 and 51.3 +/- 6.8 for PCNA labeling, and 31.8 +/- 4.2 and 18.6 +/- 3.4 for mitotic index, respectively. For the fifth group comprising cirrhotic rats that were administered alpha-tocopherol and had undergone partial hepatectomy, BrdU incorporation, PCNA labeling, and mitotic indices were 37.5 +/- 6.3, 76.5 +/- 6.2, and 27.2 +/- 4.2, respectively. When the cirrhotic liver regeneration group was compared with the normal liver regeneration group, rates of liver regeneration in the cirrhotic group were significantly depressed (P < 0.01). Although the BrdU incorporation and PCNA labeling indices of the alpha-tocopherol-administered cirrhotic liver regeneration group indicated significantly lower rates of liver regeneration when compared with the normal liver regeneration group (P < 0.05), the liver regeneration rates of the alpha-tocopherol-administered cirrhotic group were also significantly higher than those of the cirrhotic liver regeneration group that was not administered alpha-tocopherol (P < 0.01).
CONCLUSIONS: Cirrhotic livers revealed a significantly depressed capacity for regeneration following partial hepatectomy. alpha-Tocopherol administration seemed to improve the rates of regeneration in cirrhotic rats with respect to the BrdU incorporation, PCNA labeling, and mitotic indices. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10729248     DOI: 10.1006/jsre.2000.5825

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  11 in total

1.  Polyamines are required for the initiation of rat liver regeneration.

Authors:  Leena Alhonen; Tiina-Liisa Räsänen; Riitta Sinervirta; Jyrki J Parkkinen; Veli-Pekka Korhonen; Marko Pietilä; Juhani Jänne
Journal:  Biochem J       Date:  2002-02-15       Impact factor: 3.857

2.  A growth-constrained environment drives tumor progression invivo.

Authors:  S Laconi; P Pani; S Pillai; D Pasciu; D S Sarma; E Laconi
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-26       Impact factor: 11.205

3.  [Hepatocellular carcinoma and cholangiocarcinoma].

Authors:  F Rauchfuss; H Scheuerlein; M Götz; Y Dittmar; R Voigt; M Heise; U Settmacher
Journal:  Chirurg       Date:  2010-10       Impact factor: 0.955

4.  Geranylgeranylacetone suppresses inflammatory responses and improves survival after massive hepatectomy in rats.

Authors:  Hironobu Oda; Hidenori Miyake; Takashi Iwata; Kenji Kusumoto; Kazuhito Rokutan; Seiki Tashiro
Journal:  J Gastrointest Surg       Date:  2002 May-Jun       Impact factor: 3.452

5.  Hepatocyte growth factor and c-Met inhibition by hepatic cell hypoxia: a potential mechanism for liver regeneration failure in experimental cirrhosis.

Authors:  Christophe Corpechot; Veronique Barbu; Dominique Wendum; Nicolas Chignard; Chantal Housset; Raoul Poupon; Olivier Rosmorduc
Journal:  Am J Pathol       Date:  2002-02       Impact factor: 4.307

6.  Restrictive model of compensated carbon tetrachloride-induced cirrhosis in rats.

Authors:  Jean-Marc Regimbeau; David Fuks; Niaz Kohneh-Shahri; Benoît Terris; Olivier Soubrane
Journal:  World J Gastroenterol       Date:  2008-12-07       Impact factor: 5.742

7.  Effects of bicyclol on liver regeneration after partial hepatectomy in rats.

Authors:  Xiao-Min Yao; Jing Zhao; Yue Li; Yan Li
Journal:  Dig Dis Sci       Date:  2009-02-14       Impact factor: 3.199

8.  Geranylgeranylacetone prevents acute liver damage after massive hepatectomy in rats through suppression of a CXC chemokine GRO1 and induction of heat shock proteins.

Authors:  Hirofumi Kanemura; Kenji Kusumoto; Hidenori Miyake; Seiki Tashiro; Kazuhito Rokutan; Mitsuo Shimada
Journal:  J Gastrointest Surg       Date:  2008-08-06       Impact factor: 3.452

9.  Hepatocyte growth factor gene therapy accelerates regeneration in cirrhotic mouse livers after hepatectomy.

Authors:  F Xue; T Takahara; Y Yata; Y Kuwabara; E Shinno; K Nonome; M Minemura; S Takahara; X Li; E Yamato; A Watanabe
Journal:  Gut       Date:  2003-05       Impact factor: 23.059

10.  ALPPS for Hepatocellular Carcinoma Is Associated with Decreased Liver Remnant Growth.

Authors:  Daryl Kai Ann Chia; Zachery Yeo; Stanley Eu Kuang Loh; Shridhar Ganpathi Iyer; Krishnakumar Madhavan; Alfred Wei Chieh Kow
Journal:  J Gastrointest Surg       Date:  2018-01-29       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.